Wright Medical Group, Inc. has announced the launch of BIOTAPE XM™ Reinforcement Matrix, a sterile, acellular xenograft matrix for reinforcement of soft-tissue repairs in foot and ankle surgical procedures.
Second-Generation Product for Diagnosis of Discogenic Low Back Pain
Medtronic, Inc. (NYSE: MDT ), today announced the U.S. launch of the Discyphor Direct™ Catheter System, the second-generation catheter system used by physicians to obtain additional information to diagnose discogenic low back pain.
The Discyphor Direct Catheter System provides additional information to help identify which disc is causing a patient's pain. More than 100,000 patients annually undergo spinal surgery for discogenic low back pain in the United States1, but patient satisfaction from such surgeries is mixed.
Moacir Schnapp, a Memphis-based neurologist has launched a posture correction device. His innovation, called 'the iPosture', is intended to aid men and women in improving their posture that benefits their health in the long run. The iPosture is to be worn for approximately four hours each day for the initial two to four weeks in order to correct posture by establishing a habit in the user.
DiaGenic ASA is an innovative Norwegian life sciences company founded in 1998 and listed on the Oslo Stock Exchange.
DiaGenic develops patient-friendly tests for the early diagnosis of devastating diseases where early intervention is crucial for successful treatment. DiaGenic's patented method is based on identifying disease-specific gene signatures from easily available sample material such as blood.
Indian pathology labs that hope to generate business from the United Kingdom may have to invest in a front-end operation there because of issues related to legal liability in the event of faulty analysis of samples.
A team of 13 chief executives of different hospitals under the UK's National Health System (NHS) visited India recently to study the healthcare delivery service. Some Indian pathology labs have worked towards using India's relative cost advantage to attract basic pathology lab business from the UK and the United States.
Indian pathology lab chains such as SRL Ranbaxy and Metropolis have had their main lab accredited to the College of American Pathologists to project the credibility needed for outsourcing opportunities.
The pilot project of School Health Monitoring System was successfully showcased by Intel India Ltd and SHARP NGO (School Health Annual Report Programme) in association with NIIT in the presence of Hon'ble Minister of Commerce, Mr Kamal Nath.
The pilot project was done amongst 70 students in the village nearby the NIIT centre. These children were frequent users of the NIIT Kiosks- provided to them under their 'Hole in the wall' project. All the children belonged to poor or lower middle class family and most of their parents and elder siblings were laborers. The age group of the children who were included under the pilot project was 3 yrs to 15 yrs.
Biocon Limited, India's pioneering biotechnology company has announced the launch of a Safety Device inthe form of pre-filled syringes for two of its life saving products, GCSF (granulocyte-colony stimulating factor) and EPO (Erythropoietin). This innovative product has been launched in collaboration with Safety Syringes Inc. and is being introduced for the first time in India. ERYPRO Safe™ and NUFIL Safe™ will be the first two drugs that will be marketed using this novel device with other injectable products to follow in the future.
HD Medical has entered into a distribution agreement with BPL Limited for the distribution of the company's first pipeline product, ViScope 100. The distribution agreement is valued at USD$10 Million (Rs.45 Crores).
Disclosing this to media persons here today, Mr. Jay Jethwa, Managing Director and CEO of HD Medical Groupsaid, "ViScope is an Audio-Visual Cardiac Screening device that enables doctors to Visulaize the heart sounds along with hearing them better. ViScope also enables the better detection of murmurs and other heart sound components so as to achieve a very effective screening of cardiac anomalies"
India has been considered a leading player in promoting medical healthcare facilitation as an industry for some time now. With the best resources and a host of competent doctors, it has become one of the most favored healthcare destinations for a plethora of medical procedures.
What is most attractive about this phenomenon and has been a key driver is the low waiting time treatments in India; added to this is the cost of treatment, which is less than 60% of a comparable cost of treatment in countries like the US or the UK. Procedures ranging from cardiac surgery to renal transplants, gastric bypass, laparoscopic gastric banding and joint replacements are some of the treatments which prove to be very cost effective when carried out in India.
There are 158 million people in India who are overweight, of which 1.35 million take the pains of visiting nutritionists to lose weight and spend around $160 million. Furthermore, there are 40 million people in India, who suffer from diseases like Diabetes type 2. All of these people need a convenient way to prevent/cure such lifestyle diseases.
For such people, LifeMojo would provide an easy access to preventive health care experts and necessary tracking tools. LifeMojo also provides a platform to preventive health care providers to run and scale-up their existing operations. LifeMojo is accessible on the Web and mobile using GPRS/SMS with the first-of-its kind LifeMojo mobile tracker.
A lot of CROs and Pharmaceutical companies in India are working on development of new Drugs both independently and in collaboration with certain MNCs. There are very strict regulatory norms both by Indian FDA as well as US FDA which needs to be followed. Animal testing is also mandatory to check the effectiveness of different compounds and their side effects. XT-1800i V & XT-2000i V Vet Analyzer offers superior diagnostics for animal blood analysis thereby ensuring high quality standards to support Clinical trials & drug discovery.
"MRI has become the preferred choice for medical diagnosis due to its non-invasive and non-radioactive nature. Compared with other imaging modalities such as CT and Ultrasound, MRI not only provides super physical and structural feature, but also functional chemical information of the human body. However, MRI is still too expensive for widespread clinical applications in developing countries including China and India. With rising trend in cancer and other deadly diseases, there is a dire need for high quality MRI imaging at affordable cost." says Prof Q.Y. Ma, leading Scientist in the MRI field and Co-Founder of Time Medical Inc. (TiMed).
NEON Healthcare & Research Institute Limited has been founded and promoted by Mr. Sajal Dutta. Mr. Dutta is a Graduate Mechanical Engineer with post graduation in Business Administration from the prestigious Indian Institute of Management, Calcutta. He runs successful businesses in India and USA and his companies own well known brand names in international retail market. NEON Healthcare & Research Institute Limited has four divisions:
Mr. Dutta is also the Founder-promoter and Director of one of the renowned hospitals in Eastern India - Ruby General Hospital Limited, Kolkata.
Visit their web-site http://www.neonlaboratories.com/
Hayes Clinical Laboratory is a full service medical laboratory, performing tests on all body fluids. We offer the highest level of personalized service at the lowest prices in our areas.
Visit their web-site: www.hayeslab.com
In America, Hayes Clinical Laboratory is a single testing facility cornered in by the national powerhouses that dominate their industry. But, when the family-owned business tapped the overseas market, it scored a deal that could lead to dozens of clinical testing facilities in India.
Boynton Beach-based Hayes Clinical made a joint venture in June with the Neon Healthcare and Research Institute, one of the largest lab companies in Calcutta, in India's West Bengal state. They petitioned the government to set up labs in 54 hospitals and academic medical centers around that area.
DARK Daily is a concise e-news/management briefing on timely topics in clinical laboratory and anatomic pathology group management. It is a solution to the dilemma facing anyone in the laboratory profession. New developments, new technology, and changing healthcare trends make it imperative to stay informed to be successful. At the same time, the Internet, cell phones, blackberries, laptop computers, and wireless devices are overwhelming any one individual's ability to absorb this crushing Tsunami of data.
Please visit : http://www.darkdaily.com/
As part of its cost-cutting efforts, Britain may ship blood and urine samples from National Health Service (NHS) patients to India for clinical tests and in return get test results by e-mail.
Private sector hospitals are already conducting trials of the service, reducing the cost by one third and the company behind the scheme -- SRL Ranbaxy, Mumbai -- is now targeting the public sector and has already held discussions with concerned ministers.
The health department officials have met representatives of SRL Ranbaxy to hear how outsourcing to India could work. Trade Secretary Patricia Hewitt also met the representatives of the firm earlier this month.
What lies ahead for pathologists was a key theme in San Diego, California, this week at the Pathology Visions 2007 program produced by Aperio Technologies, Inc. and the California Society of Pathologists (CSP). The keynote speaker was Jared N. Schwartz, M.D., Ph.D., who is the incoming President of the College of American Pathologists (CAP).
The district health officials on Friday conducted raids on several hospitals and diagnostic centres which were found flouting rules under Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act. One hospital at Noor Khan Market in old city was also found violating strictures under the Act, officials informed.
The centres, which came under the scanner include Anu Test Tube Centre near Raj Bhavan, Yashoda Hospital at Somajiguda, Vasavi Hospital at Lakdikapul, Amaleswari Diagnostics Centre at Punjagutta, Yasar Yaha Hospital at Noor Khan market, Kamini diagnostics at Kavadiguda and Mahita diagnostics, Musheerabad, officials said.
TRANSASIA is recognized as a leading player in the Diagnostic world. It provides World Class Quality and Technology with unmatched standards of customer satisfaction.
McEvoy and Farmer report on IVD industry in India (2006) ranks Transasia as the # 1 Company in the Indian Diagnostic Industry.
It has the largest Sales and Installation base with over 15,000 installations all over the country.
The last decade has been witness to the giant strides taken by the Indian healthcare scenario, towards modernization and development- gone are the days when those who could afford it had to travel abroad to get highly specialized services such as cardiac surgery, while others had to do without it.
Today, patients from the developed Western nations are coming to India to receive specialized medical treatment. Not only is India meeting international standards, but at prices that compare very favorably with developed countries.
| /PRZOOM - Newswire/ - The rapid growth in the Indian healthcare sector is poised to be the future growth driver for the economy. India's health expenditure is among the highest for developing countries.. | |||
| Delhi, New Delhi, India, 08/04/2006 – India's healthcare services industry is expected to be very appreciable in the near future. The Indian healthcare sector is anticipated to be the future growth driver for the economy. The Indian government expects that the healthcare industry, which is currently valued at $17 billion and comprises of hospital service, healthcare equipment, managed care and pharmaceuticals would grow at a rate of 13 percent annually. The Indian healthcare industry overview indicates it has the same exponential growth potential as software and pharmaceutical industries in the country. Till now only 12% of the opportunities in Indian healthcare sector has been dug. In terms of percentage of GDP, India's expenditure on health is among the highest of the developing countries. With the gaping difference in health costs between Indian and western countries, India is now the preferred destination quality health solutions. Other reasons account to the improved healthcare sector performance through growth in pharmaceutical market and health insurance market in the country. Continue reading : http://www.przoom.com/news/7416/ | |||
Savyon Diagnostics develops, manufactures and markets diagnostic kits for the detection of infectious diseases.
The product lines are categorized according to areas of disease diagnosis:
The tests are based on various immunological techniques (ELISA, MIF, IPA, rapid single tests). Savyon holds several patents related to these products, has the "know how" of producing the antigens and using cutting edge technology to coat the plates and manufacture the kits.
Savyon is accredited with the highest international quality standards of research, development and manufacture, including ISO 13485:2003 and ISO 13485:1996 under Canada (Canadian certificate). The company's products are all CE certified and some are FDA approved.
Sales to laboratories, research institutions and clinicians are supported by an extensive worldwide network of over 80 distributors.
Span Diagnostics Ltd. is a pioneer and trend setter of high quality products for pathology & clinical laboratories in the Indian diagnostics industry. A globally acknowledged and fastest growing diagnostic company with a successful track record of over 3 decades having Asia's one of the largest state-of-the-art ISO-9001:2000, WHO cGMP accredited advanced manufacturing facilities with ISO 13485 & CE accredited products. We have our marketing activities across India and 68 countries worldwide. SPAN services end users and distributors with ready to use testing kits and customized OEM products.
KRISHGEN is a proprietary company engaged in diagnostic and research instruments, tools, kits and reagents.
We not only believe in aggressive but Scientific, methodical, systematic & above all Knowledgeable marketing.
Mr.Pradeep K. Singhal, a well known figure in the Indian & overseas Diagnostic Industry started this company & still is the Managing Director of the Company and Heads the Research and Development as well.
We are also proud to state that we have set up a state of the art manufacturing facilities at Parwanoo in Solan, H.P where most of the Molecular Biology products & Real Time PCR kits, Gel based PCR kits will be manufactured. This is the first unit of it's kind in India. We also have a fairly advanced R & D laboratory in Delhi.
| In the context of exciting growth in the country, leading Indian biotechnology companies recognize the need for a forum that would represent India's unique Biotech environment. A forum that would generate a symbiotic interface between the industry, the government, academic and research bodies, and domestic and international investors. ABLE,the Association of Biotechnology Led Enterprises was the natural result of this need and is envisaged as the collective face of the Indian Biotech industry. |
| ABLE's Objectives |
Visit: http://www.ableindia.org/ |
A very different story can be told about the countries that hold three spots on the roster of the top ten IVD markets: China, Brazil, and India. These three rapidly developing countries are now spending more than $2.5 billion per year on IVD products. With double-digit annual growth, this sum will likely double to $5.1 billion in 2015.
China, Brazil, and India are currently ranked sixth, ninth, and tenth, respectively, among IVD markets worldwide. By 2015, they will be ranked third, seventh, and ninth. For producers of IVD instrumentation, these three countries hold a disproportionate importance. There are 52,000 clinical labs in these three countries, only 16,000 of which are automated at present. This year, they will buy more than 8000 automated hematology systems, more than 4000 automated routine chemistry systems, and nearly 2500 automated immunoassay systems.
These three markets have some very interesting similarities and differences. This article compares China, Brazil, and India with regard to the following: market value and accessibility for overseas IVD companies, number and character of their clinical labs, competitiveness of indigenous producers, distribution challenges, and product registration challenges.
Focusing on China, Brazil, and India
Vision To make a difference in the quality of life of people suffering from poverty-related diseases in the developing world. Mission The Foundation for Innovative New Diagnostics (FIND) is dedicated to the development of rapid, accurate and affordable diagnostic tests through public-private partnerships. Its mission is driven by the conviction that good health is central to winning the war against poverty and that correct diagnosis is a crucial first step towards establishing health and efficient use of resources. To achieve this mission, FIND will Employ best scientific and business practices by developing and facilitating appropriate use of improved diagnostic tests within public health systems and thereby help decrease global health inequities. Contribute to the goals of organizations such as the STOP TB Partnership, Roll Back Malaria, Tropical Diseases Research, among others, by fostering the transformation of proven biological principles into effective products with demonstrated impact on disease control. Leverage investments against affordability, hence helping to ensure equitable access to diagnostic products for those most in need of them. Objectives Develop, in partnership with academia, public and private research institutes and industry, new diagnostic approaches that have been proven in principle and to transform them into effective products for identifying poverty-related diseases. Compare and evaluate these products in coordinated laboratory and field trials as part of FIND's milestone process from customer requirement to access to cheap and effective diagnosis. |
Founded in 1973 as a fine chemical manufacturer, Loba Chemie has grown into a customer-focused global supplier of high quality chemicals, laboratory supplies and equipment. All our facilities are ISO 9001:2000 certified. The New plant at Tarapur will operate as per Good Manufacturing Practices (cGMP) Standards.
Tarapur has a state of the art Quality Assurance Laboratory equipped with technologically advanced equipment for testing and maintaining the consistency and quality of all its products.
Loba has also introduced a new line of product range called LOBA LIFE to deal in Laboratory Instruments and Safety Products.
Loba Chemie is being represented in over 85 countries and is successful in gaining the market share with its wide range of quality products. Special Packaging to meet international guidelines gives Loba Chemie the ability to ship its products by Air, Sea and Land to any part of the globe.
Visit:http://www.lobachemie.com/laboratory-chemicals/products.asp?code=B
The leader in the field of in -vitro diagnostics with two decades of service to the laboratory medicine. Lab Diagnostics markets state-of-the-art equipments and reagent kits, which are benchmarked by the industry.
We offer a full range of diagnostic solutions for laboratories of all sizes in the field of:
 | Clinical Chemistry |
| Immunology Diagnosis |
| Hematology Diagnosis |
| Rapid Diagnostics Visit : http://www.nicholaspiramal.com/pro_diagnostics_lab.htm for more information |
Roche Diagnostics India is part of the International F. Hoffman-La Roche Group worldwide that was founded in 1896 in Basel, Switzerland. Roche has grown from a small drug laboratory into one of the world's leading research- based Healthcare companies. Today, Roche ranks among the top ten pharmaceutical companies in the world and is known for many innovative contributions to medicine.
Roche and Boehringer Mannheim, two of the most experienced innovators in diagnostics, joined forces in 1998 to create a new, fully-integrated approach to health management worldwide.
Visit : http://www.roche-diagnostics.co.in/ for more information
| |
Lab-Care Diagnostics (India) Pvt. Ltd. was founded in 1982 under the name of Lab-Care Diagnostics (India) Pvt. Ltd. The company is privately owned by its two founders, Mr P.B. Bhatia & Mr Ravi Chadha. The company was first started as a trading house for diagnostic reagent supplies. Since June 2001, Lab-Care Diagnostics under went change in constitution & is now known as Lab-Care Diagnostics (India) Pvt. Ltd. situated in Mumbai started its state of the art facility in Sarigam, Dist Valsad in Gujarat. Since the modest inception of Lab-Care Diagnostics (India) Pvt. Ltd. today the company has become nationally known as one of the leading manufacturers in the medical device industry especially in the field of clinical chemistry reagents, immuno-chromatographic rapid test, serology test & urine analysis strips. The company is also known as a supplier of high quality clinical diagnostics reagents and test kits. Without the continuing dedication, hard work, innovation and loyalty by its staff, and with the continuing support of our domestic customers, Lab-Care Diagnostics (India) Pvt. Ltd. success would be impossible, with this in mind, the company will strive to continue fulfilling the needs and expectations of both its dedicated staff as well as its valued customers. Lab-Care Diagnostics (India) Pvt. Ltd. will constantly adopt new ideas and challenges in an effort to guarantee its continued success. Visit : http://www.labcarediagnostics.com/ for more information |
Since 1985 , Embee Diagnostics has been striving to introduce Diagnostic products that offer our customers the latest in technology, an unmatched range, quality, convenience and economy. The company, committed and dedicated towards excellent customer service, has created history by establishing the name of the organization as one of the best managed diagnostic solution providers in the entire country .
The company has been rewarded with a number of awards for outstanding performances by organizations such as Bayer, Johnson & Johnson, Sanofi, Labsystems, Ranbaxy etc.
Welcome to the complete Indian Diagnostics Site - www.embeediagnostics.com . The aim of this site is to serve the Labs, Hospitals and blood banks spread around the world - big or small, to provide an exhaustive range of Diagnostic products and unmatched services in Diagnostic Trade . Embee Diagnostics provides:
-Laboratory Instruments, Diagnostic Reagents, Accessories etc.
-Whether you are looking for Fully Automated Immunoassay Systems, Chemistry Analyzers or Diagnostic Kits, Embee can provide you with anything and everything.
-At Embee, we have products with Latest Technology - PCR, ELISA, IFA, Fully Automated Immunoassay Systems and others are all available with us.
-Embee is the complete Diagnostics Solution Provider ,whether a Blood Bank, Pathology Lab, Microbiology Lab or Research Lab - we have it all.
Visit web-site: http://www.embeediagnostics.com/ for more inforamtion
